Package 0574-0295-01

Brand: hydromorphone hydrochloride

Generic: hydromorphone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0574-0295-01
Digits Only 0574029501
Product NDC 0574-0295
Product ID 0574-0295_8b576b81-17fc-4251-acc3-6e1b9e18030c
Description

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0295-01)

Marketing

Marketing Status
Marketed Since 2015-05-22
Brand hydromorphone hydrochloride
Generic hydromorphone hydrochloride
Sample Package No

Linked Drug Pages (1)

hydromorphone hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8b576b81-17fc-4251-acc3-6e1b9e18030c", "openfda": {"unii": ["L960UP2KRW"], "rxcui": ["902729", "902736", "902741", "1306898"], "spl_set_id": ["780a2616-0392-4715-bc50-71799bea1957"], "manufacturer_name": ["Padagis US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0295-01)", "package_ndc": "0574-0295-01", "marketing_start_date": "20150522"}], "brand_name": "hydromorphone hydrochloride", "product_id": "0574-0295_8b576b81-17fc-4251-acc3-6e1b9e18030c", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "0574-0295", "dea_schedule": "CII", "generic_name": "hydromorphone hydrochloride", "labeler_name": "Padagis US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "hydromorphone hydrochloride", "active_ingredients": [{"name": "HYDROMORPHONE HYDROCHLORIDE", "strength": "16 mg/1"}], "application_number": "ANDA204278", "marketing_category": "ANDA", "marketing_start_date": "20150522", "listing_expiration_date": "20271231"}